Medical device giant Medtronic has announced that it has acquired Menlo Park, Calif.-based Medina Medical. The deal includes an initial payment of $150 million plus additional payments for achieving key milestones.
Medina focuses on developing treatments for vascular abnormalities of the brain, including cerebral aneurysms.
Medina’s embolization device is an intrasaccular 3D mesh implant that fills the inside of a brain aneurysm. The implant provides a scaffold across the aneurysm neck, conforms to the shape of the aneurysm and reduces blood flow.
The device has CE Mark authorization but is not available in the U.S. — Michael Cipriano
